REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2008 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT, dated as of October 14, 2008 (this “Agreement”), is by and between INTEGRATED BIOPHARMA, INC., a Delaware corporation (the “Company”), and each of the investors whose names appear on the signature pages hereof. Such investors are each referred to herein as an “Investor” and, collectively, as the “Investors”. The Company has agreed, on the terms and subject to the conditions set forth in the First Amendment to Amended and Restated Securities Purchase Agreement and 8% Senior Secured Notes, dated as of the date hereof (the “Amendment”), between the Company and the Investors, to issue to the Investors Warrants (the “Warrants”) exercisable for the Company’s Common Stock, par value $0.002 per share (the “Common Stock”).
OFWarrant • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2008 Company Industry JurisdictionThis Warrant has been issued pursuant to the First Amendment to Amended and Restated Securities Purchase Agreement and 7% Senior Secured Notes, dated as of the date hereof (the “Amendment”), by and between the Company, the Holder and the other investors party thereto. The Amendment amends, among other things, certain provisions of the Amended and Restated Securities Purchase Agreement, dated as of February 21, 2008 (the “Securities Purchase Agreement”), by and between the Company, the Hodler and the other investors party thereto.
AMENDED AND RESTATED FIRST AMENDMENT TO AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT AND 8% SENIOR SECURED NOTESSecurities Purchase Agreement • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED FIRST AMENDMENT TO AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT AND 8% SENIOR SECURED NOTES, dated as of October 20, 2008 (this “Amendment”), is by and between Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and each of the investors whose names appear on the signature pages hereof. Such investors are each referred to herein as an “Investor” and, collectively, as the “Investors”.